Skip to content

Drug interactions

Danicopan + Glibenclamide

Severity: Moderate

Danicopan and Glibenclamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Danicopan inhibits the breast cancer resistance protein (BCRP) efflux transporter, which can raise systemic exposure to glyburide. Higher glyburide levels may strengthen its glucose-lowering effect and increase the risk of hypoglycemia.

What this interaction means in plain words

Danicopan and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Danicopan belongs to Miscellaneous; Glibenclamide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Danicopan inhibits BCRP-mediated efflux, which increases glyburide plasma concentrations.

What to do

Monitor blood glucose when danicopan is started or stopped and reduce the glyburide dose if hypoglycemia occurs. Teach patients to recognize hypoglycemia symptoms.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Danicopan and Glibenclamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Danicopan with Glibenclamide?

MediHelp rates the interaction as moderate. Danicopan and Glibenclamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Danicopan inhibits the breast cancer resistance protein (BCRP) efflux transporter, which can raise systemic exposure to glyburide. Higher glyburide levels may strengthen its glucose-lowering effect and increase the risk of hypoglycemia.

How serious is the interaction between Danicopan and Glibenclamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when danicopan is started or stopped and reduce the glyburide dose if hypoglycemia occurs. Teach patients to recognize hypoglycemia symptoms.

What other medicines interact with Glibenclamide?

MediHelp also lists interactions of Glibenclamide with, for example, Bosentan, Cholic acid, Ciprofloxacin. The full list is on the Glibenclamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in